SwasthVayu—By CSIR-NAL

Current Context: CSIR-National Aerospace Laboratories (NAL) Bangalorehas developeda Non-Invasive BilevelPositive Airway Pressure (BiPAP) Ventilator.

• The BiPAP ventilator has been named as ‘SwasthVayu’.
• It has been developed in a record time of 36 days to treat COVID-19 patients.
• Its technical configuration is that it is a microcontroller-based precise closed-loop adaptive control systemwith a built-in biocompatible 3D printed manifoldcoupler with Highly Efficient Particulate Air Filter (HEPA Filter).
• It is designed with an unique features which help to alleviate the fear of the virus spread
• The features included in it are Spontaneous, CPAP, Timed, AUTO BIPAP modeswith provision to connect Oxygen concentratoror Enrichment unit externally.
• It has undergone various biomedical tests at NAL Health Centre and has been accredited by NABL in terms of safety and performance.
• SwasthVayu machine is simple to use without any specialized nursing, cost-effective, compact and configured with a majority of indigenous components.
• BIPAP Non-Invasive Ventilator has been developed with an externally connected Oxygen concentrator which will be ideal to treat moderate or mid-stage severe COVID-19 patients who do not require intubation and invasive ventilation.

Question:

Q.1 Which of the following organisation has developed BiPAP Non-Invasive ‘Swasth Vayu’ Ventilator in a record time of 36 days to treat COVID-19 patients?
a. DRDO
b. Bharat Biotech
c. IIT-Kharagpur
d. CSIR-National Aerospace Laboratories